<SEC-DOCUMENT>0001824293-23-000152-index.html : 20230814
<SEC-HEADER>0001824293-23-000152.hdr.sgml : 20230814
<ACCEPTANCE-DATETIME>20230814160620
ACCESSION NUMBER:		0001824293-23-000152
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230810
FILED AS OF DATE:		20230814
DATE AS OF CHANGE:		20230814

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Baker David Charles
		CENTRAL INDEX KEY:			0001844060

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40034
		FILM NUMBER:		231169874

	MAIL ADDRESS:	
		STREET 1:		100 N. 18TH STREET
		STREET 2:		SUITE 300
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GRI BIO, Inc.
		CENTRAL INDEX KEY:			0001824293
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				824369909
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2223 AVENIDA DE LA PLAYA
		STREET 2:		SUITE 208
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		(619) 400-1171

	MAIL ADDRESS:	
		STREET 1:		2223 AVENIDA DE LA PLAYA
		STREET 2:		SUITE 208
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Vallon Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20200910
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wk-form4_1692043540.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wk-form4_1692043540.html

Document 1 - RAW XML: wk-form4_1692043540.xml

</DOCUMENT>
</SEC-DOCUMENT>